ASCO currently provides information for patients through Cancer.Net, and to help improve public access to medical research from its journals, ASCO has joined the growing list of organizations making their journal content freely available through the Access to Research program. This initiative helps make research from more than 9,700 journals available at nearly all public libraries in the United Kingdom.
This year, ASCO is hosting a first-of-its kind meeting focused on innovation in cancer – exploring what’s possible when medicine, technology and scientific discovery intersect. The meeting, called ASCO Breakthrough: A Global Summit for Oncology Innovators, will take place October 11-13, 2019 in Bangkok, Thailand.
New research suggests women with ovarian cancer are not undergoing genetic testing, despite existing clinical practice guidelines that recommend nearly all women with ovarian cancer receive genetic testing.
Developing and validating predictive markers for treatment outcomes and then confirming how those markers can be used to help patients and clinicians choose appropriate therapies is often a long step-wise process. New research presented at the 2019 ASCO-SITC Clinical Immuno-Oncology Symposium points to multiple potential approaches for determining which patients are most likely to benefit from immunotherapy.